ORIGINAL RESEARCH article
Front. Surg.
Sec. Orthopedic Surgery
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1701518
This article is part of the Research TopicNew Advances in Prosthetic Surgery of Large JointsView all 9 articles
Long-Term Survival Outcomes of Wagner™ Conical Stems in Crowe Non-IV Hip Dysplasia: A Retrospective Analysis
Provisionally accepted- 1University of Insubria, Department of Biotechnology and Life Sciences, Varese, Italy
- 2Aziende Socio Sanitarie Territoriale dei Sette Laghi, Varese, Italy
- 3Universita degli Studi dell'Insubria, Varese, Italy
- 4Ospedale Vito Fazzi, Lecce, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Total hip arthroplasty (THA) is one of the most frequently performed orthopedic procedures. Developmental dysplasia of the hip (DDH) presents specific anatomical challenges that require tailored implant designs. Wagner™ conical stems were developed to address the morphological alterations of dysplastic femur, offering potential advantages in stability and functional restoration. This study assesses the long-term survival and clinical outcomes of Wagner™ conical stems in patients with Crowe non-IV DDH. Materials and Methods: This retrospective study included primary THAs performed between 2003 and 2015 using Wagner™ conical stems exclusively in patients with DDH. Only cases with complete clinical and radiographic follow-up were analyzed, excluding those lost to follow-up or revised. The evaluated outcomes were prosthetic survival rate, clinical performance assessed with the Modified Harris Hip Score (mHHS), and radiographic findings at final follow-up. Results: Forty-five patients (57 hips) met the inclusion criteria. The mean age at surgery was 56.5 years (range, 33–76), with a mean follow-up of 15 years (range, 8–20). Kaplan–Meier analysis showed a survival rate of 95.7% at 10 years and approximately 80.5% at 20 years, with an overall survival rate of 89.5% at the final follow-up. The main cause of failure was aseptic loosening, followed by infection, recurrent dislocation, and metallosis. Among hips with retained implants, 86.3% (44/51) achieved an mHHS >70, indicating satisfactory functional recovery. The mean mHHS was 88.6 +- 14.3 (Range, 62–100), with a median of 92 and a mode of 100. Conclusion: Wagner™ conical stems provide durable fixation and favorable long-term functional outcomes in Crowe non-IV DDH, with high survival rates and low complication incidence over extended follow-up.
Keywords: Hip dysplasia development, Wagner stem, Total hip arthroplasty, orthopedic implants survival, THA complication
Received: 08 Sep 2025; Accepted: 06 Oct 2025.
Copyright: © 2025 D'Angelo, Pautasso, Antognazza, Monestier, Gervasini, Filipponi, Bernardi and Riva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Fabio D'Angelo, fabio.dangelo@uninsubria.it
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.